Clinical Trials Logo

Atypical Facial Pain clinical trials

View clinical trials related to Atypical Facial Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT05257655 Completed - Clinical trials for Glossopharyngeal Neuralgia

Ganglionic Local Opioid Analgesia at the Ganglion Cervicale Superius

GLOA-MRT
Start date: January 9, 2023
Phase: N/A
Study type: Interventional

The blockade of the superior cervical ganglion (GCS) of the sympathetic trunk is a very special form of therapy. The transoral blocking technique, also known as GLOA (ganglionic local opioid analgesia), is very suitable for achieving GCS. A total of 5 μg of sufentanil in 2 ml of sodium chlorid are applied. Since no imaging evidence of the injected substances has been published for a GLOA in a living person, it is planned to carry out an MRI examination immediately after the ganglionic local opioid analgesia in order to show the spread and distribution pattern of the injected substance. It is also planed to show a correlation of the spread of the injected substance with the efficacy of the intervention. To determine the interrater reliability, the GLOA is carried out alternately by 2 different examiners and the existing MRI images of the GLOA are assessed by an radiologist and anatomist in a blinded manner. In a follow-up after 1 and 3 months, the questionnaires and pain scores are evaluated again.

NCT ID: NCT02024724 Completed - Clinical trials for Atypical Facial Pain

Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain

Start date: November 2013
Phase: Phase 4
Study type: Interventional

Trigeminal neuralgia is a craniofacial pain syndrome that is typically characterized by unilateral severe, recurrent, electrical pain in one or more distributions of the trigeminal nerve. Current treatment strategies include oral medications as first line therapy with surgical interventions reserved for those patients who are refractory to medications or unable to tolerate medication side effects. Despite these current treatment options, many patients continue to have symptoms. Ultrasound-guided trigeminal nerve block allows for fine adjustment of the needle tip and direct observation of the medicine. Local anesthetic and steroids have been successfully used for diagnostic and or therapeutic nerve pain with great success. Steroids can be short or long acting in duration with varying side effects. If there exists a difference in duration of action, using the longer acting drug will provide a greater period of symptom relief for the patient and may allow the patient to undergo fewer interventional procedures.

NCT ID: NCT01920087 Withdrawn - Clinical trials for Atypical Facial Pain

Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain

AFP
Start date: March 2014
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to test the efficacy of ATNC05 in the treatment of Atypical Facial Pain (AFP), also known as Persistent Idiopathic Facial Pain (PIFP). This research project targets patients with chronic constant facial pain and excludes patients with primarily paroxysmal pain.